← Eichor
Condition: Mild To Moderate Dementia Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Mild To Moderate Dementia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET
Phase 3 · 126 location(s) · Bristol-Myers Squibb · NCT06976203A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease P
Phase 2 · 2 location(s) · Elixiron Immunotherapeutics Inc. · NCT06745583Phase 3 Clinical Trial of Wujia Yizhi Granules in the Treatment of Mild-to-moderate Alzheimer's Dementia (Syndrome of De
Phase 3 · 1 location(s) · Sichuan Jishengtang Pharmaceutical Co., Ltd. · NCT06534723Deep Repetitive Transcranial Magnetic Stimulation (rTMS) of the Precuneus for Alzheimer Disease (AD)
Phase 1/Phase 2 · 1 location(s) · University of California, Los Angeles · NCT06597942Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)
Phase N/A · 1 location(s) · VA Office of Research and Development · NCT04124029A Phase 3 Study of Rotigotine in Combination with Rivastigmine in Mild to Moderate Alzheimer's Disease
Phase 3 · 1 location(s) · I.R.C.C.S. Fondazione Santa Lucia · NCT06702124Semantic Rehabilitation for Patients With Primary Progressive Semantic Aphasia
NA · 1 location(s) · University Hospital, Toulouse · NCT04957537Efficacy of RGn600 in Patients With Mild-to-moderate Alzheimer's Disease
NA · 6 location(s) · REGEnLIFE SAS · NCT05926011Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
NA · 1 location(s) · Herrick Medical LLC · NCT05295615Pulsed Electromagnetic Field Treatment With Dementia Patients
NA · 1 location(s) · Herrick Medical LLC · NCT06862557A Study of NTRX-07 in Participants With Alzheimer's Disease
Phase 2 · 6 location(s) · NeuroTherapia, Inc. · NCT07058688An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease
Phase 4 · 50 location(s) · Green Valley (Shanghai) Pharmaceuticals Co., Ltd. · NCT05908695Dyadic Personalized Home-Based Activity Program for Mild-to-Moderate Dementia Patients Post-Discharge
NA · 1 location(s) · Fujian Medical University · NCT07081750A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Phase 3 · 116 location(s) · Bristol-Myers Squibb · NCT06976216A Study to Assess Safety and Tolerability and to Explore Efficacy of NSC001 in Mild to Moderate Alzheimer's Disease
Phase 1/Phase 2 · 10 location(s) · NSC-Therapeutics · NCT06995573Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease
Phase 4 · 1 location(s) · University Hospital, Montpellier · NCT05924425Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PE
Phase N/A · 26 location(s) · GAP Innovations, PBC · NCT06584357CST+MST Intervention on People Living With Mild-to-moderate Dementia
NA · 1 location(s) · Istituto Superiore di Sanità · NCT07625241Allogeneic Adipose Tissue Derived-stem Cells in Alzheimer Disease
Phase 1/Phase 2 · 1 location(s) · University Hospital, Toulouse · NCT07367815Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheime
Phase 1 · 1 location(s) · Regeneration Biomedical, Inc. · NCT05667649The Feasibility and the Efficacy of the Full-immersive Virtual Reality Cognitive Training in Patients With Mild or Moder
NA · 1 location(s) · Chang Gung Memorial Hospital · NCT07033468A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RE
Phase 4 · 5 location(s) · Alpha Cognition, Inc · NCT07633470
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.